Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (101-110 of 434) with videos related to

Pageof 44
Sort By:
The Lancet. Rheumatology|January 22, 2024
Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trialNaomi J Patel, David R W Jayne, Peter A Merkel, et al.
Arthritis Care & Research|April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosisAlexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2025
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With PolyangiitisMichael E Wechsler, Jared Silver, Gerhard Wolff, et al.
Arthritis Care & Research|March 25, 2024
Patient-Reported Sinonasal Symptoms and Risk of Relapse in Antineutrophil Cytoplasmic Antibody-Associated VasculitisEllen Romich, Shubhasree Banerjee, Naomi Amudala, et al.
Arthritis and Rheumatism|April 11, 2003
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunctionDimitrios Vassilopoulos, John L Niles, Alexandra Villa-Forte, et al.
Journal of the American Dietetic Association|December 7, 2007
Nutrient status of adults with cystic fibrosisCatherine M Gordon, Ellen J Anderson, Karen Herlyn, et al.
The Journal of Rheumatology|July 5, 2011
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitisPeter A Merkel, Sibel Z Aydin, Maarten Boers, et al.
Rheumatology (Oxford, England)|October 16, 2025
Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritisDesiré Casares-Marfil, Güher Saruhan-Direskeneli, Peter C Grayson, et al.
Arthritis Care & Research|July 18, 2013
Illness perceptions and fatigue in systemic vasculitisPeter C Grayson, Naomi A Amudala, Carol A Mcalear, et al.
The Journal of Rheumatology|August 3, 2017
Severe Infection in Antineutrophil Cytoplasmic Antibody-associated VasculitisAladdin J Mohammad, Mårten Segelmark, Rona Smith, et al.
Pageof 44

Showing results (101-110 of 434) with videos related to

Sort By:
Pageof 44
The Lancet. Rheumatology|January 22, 2024
Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trialNaomi J Patel, David R W Jayne, Peter A Merkel, et al.
Arthritis Care & Research|April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosisAlexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 26, 2025
Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With PolyangiitisMichael E Wechsler, Jared Silver, Gerhard Wolff, et al.
Arthritis Care & Research|March 25, 2024
Patient-Reported Sinonasal Symptoms and Risk of Relapse in Antineutrophil Cytoplasmic Antibody-Associated VasculitisEllen Romich, Shubhasree Banerjee, Naomi Amudala, et al.
Arthritis and Rheumatism|April 11, 2003
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunctionDimitrios Vassilopoulos, John L Niles, Alexandra Villa-Forte, et al.
Journal of the American Dietetic Association|December 7, 2007
Nutrient status of adults with cystic fibrosisCatherine M Gordon, Ellen J Anderson, Karen Herlyn, et al.
The Journal of Rheumatology|July 5, 2011
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitisPeter A Merkel, Sibel Z Aydin, Maarten Boers, et al.
Rheumatology (Oxford, England)|October 16, 2025
Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritisDesiré Casares-Marfil, Güher Saruhan-Direskeneli, Peter C Grayson, et al.
Arthritis Care & Research|July 18, 2013
Illness perceptions and fatigue in systemic vasculitisPeter C Grayson, Naomi A Amudala, Carol A Mcalear, et al.
The Journal of Rheumatology|August 3, 2017
Severe Infection in Antineutrophil Cytoplasmic Antibody-associated VasculitisAladdin J Mohammad, Mårten Segelmark, Rona Smith, et al.
Pageof 44